|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Checkmate Pharmaceuticals (NASDAQ: CMPI) through any online brokerage.
The latest price target for Checkmate Pharmaceuticals (NASDAQ: CMPI) was reported by B of A Securities on September 1, 2020. The analyst firm set a price target for 19.00 expecting CMPI to rise to within 12 months (a possible 202.55% upside). 4 analyst firms have reported ratings in the last year.
The stock price for Checkmate Pharmaceuticals (NASDAQ: CMPI) is $6.28 last updated Tue Jun 22 2021 20:00:04 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Checkmate Pharmaceuticals.
There is no upcoming split for Checkmate Pharmaceuticals.
Checkmate Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.